VB
About
Viva Biotech offers global innovative drug R&D companies one-stop comprehensive services ranging from early structure-based drug R&D to commercial drug delivery. Using its advantages in the field of structure-based drug discovery (SBDD) technology, it provides global partners with CRO services in the new drug research stage and has established X-ray protein crystal technology, cryo-electron microscopy (Cryo-EM), and affinity mass spectrometry screening technology (ASMS), surface plasmon resonance (SPR), hydrogen-deuterium exchange mass spectrometry (HDX-MS), computer-aided drug design, and other advanced technology platforms.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 1,074 investors are based in Shanghai, Shanghai, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Shanghai, China
Contact Information
Find more investors like Viva
Search Investors